Dr. Hamid Ghandehari’s R01 project “Biological Fate and the Biocompatibility of Silica-Based Nanocontructs” recently received funding from the National Institute of Environmental Health Sciences
Dr. Hamid Ghandehari’s R01 project “Biological Fate and the Biocompatibility of Silica-Based Nanocontructs” recently received funding from the National Institute of Environmental Health Sciences. The research aims to address the detailed understanding of the immunotoxicity (function and fate) of silica nanoparticles as a function of their physiochemical properties in human monocytes and Th1 and Th2 in-vivo models. Dr. Ghandehari’s research team includes Research Associate Dr. Nitish Khurana, and is in collaboration with Dr. Jolanta Jedrzkiewicz (Pathology) and Dr. Marina Dobrovolskaia from the Nanotechnology Characterization Laboratory of Frederick National Laboratory for Cancer Research.